These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30579635)

  • 1. A Rare Presentation of Myelin Oligodendrocyte Glycoprotein IgG-Associated Optic Neuritis.
    Baby N; Varghese P; George SK; Aneesh MK
    Pediatr Neurol; 2019 Mar; 92():78-79. PubMed ID: 30579635
    [No Abstract]   [Full Text] [Related]  

  • 2. Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis.
    Jitprapaikulsan J; Chen JJ; Flanagan EP; Tobin WO; Fryer JP; Weinshenker BG; McKeon A; Lennon VA; Leavitt JA; Tillema JM; Lucchinetti C; Keegan BM; Kantarci O; Khanna C; Jenkins SM; Spears GM; Sagan J; Pittock SJ
    Ophthalmology; 2018 Oct; 125(10):1628-1637. PubMed ID: 29716788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial.
    Chen JJ; Tobin WO; Majed M; Jitprapaikulsan J; Fryer JP; Leavitt JA; Flanagan EP; McKeon A; Pittock SJ
    JAMA Ophthalmol; 2018 Apr; 136(4):419-422. PubMed ID: 29470571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentation of optic neuritis with autoantibodies anti-myelin oligodendrocyte glycoprotein.
    Ducloyer JB; Michel L; Wiertlewski S; Lebranchu P
    Eur J Ophthalmol; 2019 Mar; 29(2):257-261. PubMed ID: 29972029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sjögren Disease and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis.
    Mittal A; Baig IF; Merchant AG; Chen JJ; Choi JJ; Goldberg A; Adesina OO
    J Neuroophthalmol; 2021 Mar; 41(1):e48-e50. PubMed ID: 32235221
    [No Abstract]   [Full Text] [Related]  

  • 6. Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis Presenting as Idiopathic Orbital Inflammatory Syndrome.
    Wagley S; Wang Y; McClelland CM; Chen JJ; Lee MS
    J Neuroophthalmol; 2021 Mar; 41(1):e46-e47. PubMed ID: 32108670
    [No Abstract]   [Full Text] [Related]  

  • 7. Retrospective analysis of children with myelin oligodendrocyte glycoprotein antibody-related disorders.
    Konuskan B; Yildirim M; Gocmen R; Okur TD; Polat I; Kilic H; Saltik S; Ozturk Z; Gucuyener K; Altunbasak S; Celik T; Kose G; Yilmaz A; Komur M; Kayilioglu H; Anlar B
    Mult Scler Relat Disord; 2018 Nov; 26():1-7. PubMed ID: 30212767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Myelin Oligodendrocyte Glycoprotein Optic Neuritis or Neuroretinitis?
    Lee AR; El-Dairi MA
    JAMA Ophthalmol; 2018 Oct; 136(10):e182928. PubMed ID: 30326075
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical Characteristics of Pediatric Optic Neuritis With Myelin Oligodendrocyte Glycoprotein Seropositive: A Cohort Study.
    Chen Q; Zhao G; Huang Y; Li Z; Sun X; Lu P; San Y; Wang M; Tian G
    Pediatr Neurol; 2018 Jun; 83():42-49. PubMed ID: 29778487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelin oligodendrocyte glycoprotein-positive optic neuritis masquerading as pseudotumor cerebri at presentation.
    Lotan I; Brody J; Hellmann MA; Bialer O; Ganelin-Cohen E; Michaeli N; Marignier R; Stiebel-Kalish H
    J Neurol; 2018 Sep; 265(9):1985-1988. PubMed ID: 29938337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent Bilateral Myelin Oligodendrocyte Glycoprotein Antibody Optic Neuritis in a Leber Hereditary Optic Neuropathy Carrier.
    Raviskanthan S; Perera N; Fok A
    J Neuroophthalmol; 2020 Jun; 40(2):246-247. PubMed ID: 31842145
    [No Abstract]   [Full Text] [Related]  

  • 12. Myelin oligodendrocyte glycoprotein-IgG-associated optic neuritis.
    Chun BY; Cestari DM
    Curr Opin Ophthalmol; 2018 Nov; 29(6):508-513. PubMed ID: 30281030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelin Oligodendrocyte Glycoprotein-IgG-positive Recurrent Bilateral Optic Papillitis with Serous Retinal Detachment.
    Kon T; Hikichi H; Ueno T; Suzuki C; Nunomura J; Kaneko K; Takahashi T; Nakashima I; Tomiyama M
    Intern Med; 2018 Nov; 57(22):3307-3312. PubMed ID: 29780155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unilateral Leptomeningeal Enhancement in Myelin Oligodendrocyte Glycoprotein Immunoglobulin G-Associated Disease.
    Budhram A; Kunchok AC; Flanagan EP
    JAMA Neurol; 2020 May; 77(5):648-649. PubMed ID: 32119057
    [No Abstract]   [Full Text] [Related]  

  • 15. Differences in Clinical Features of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis in White and Asian Race.
    Padungkiatsagul T; Chen JJ; Jindahra P; Akaishi T; Takahashi T; Nakashima I; Takeshita T; Moss HE
    Am J Ophthalmol; 2020 Nov; 219():332-340. PubMed ID: 32681910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facial Nerve Involvement Accompanying Optic Neuritis Secondary to Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorder.
    Chen Z; Saini M; Loo JL
    J Neuroophthalmol; 2021 Sep; 41(3):e378-e380. PubMed ID: 33136679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of myelin oligodendrocyte glycoprotein antibodies for detection of demyelinating optic neuritis].
    Wei SH; Zhao Y
    Zhonghua Yan Ke Za Zhi; 2017 Nov; 53(11):874-877. PubMed ID: 29141393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis and Optic Neuritis After COVID-19 Vaccination and Relapsing Optic Neuritis After COVID-19 Infection.
    Huang KI; Cheng CK; Peng PH
    J Neuroophthalmol; 2024 Jun; 44(2):e219-e221. PubMed ID: 36857140
    [No Abstract]   [Full Text] [Related]  

  • 19. Optic perineuritis with anti-myelin oligodendrocyte glycoprotein antibody.
    Yanagidaira M; Hattori T; Emoto H; Kiyosawa M; Yokota T
    Mult Scler Relat Disord; 2020 Feb; 38():101444. PubMed ID: 31711001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient MOG antibody seroconversion associated with immunomodulating therapy.
    Pawlitzki M; Campe C; Rolfes L; Heinze HJ; Leypoldt F; Wandinger KP; Reindl M; Wildemann B; Jarius S; Körtvelyessy P
    Mult Scler Relat Disord; 2020 Jan; 37():101420. PubMed ID: 32172994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.